search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Biocept, Inc.

    (NASDAQ:BIOC)

    $0.96

    $-0.03

    -2.88%

    Biocept, Inc. Chart

    BIOC Stock Price Today

    Biocept, Inc. (BIOC) stock declined over -2.88% intraday to trade at $0.96 a share on NASDAQ. The stock opened with a loss of -8.57% at $1.03 and touched an intraday high of $1.06, falling -3.03% against the last close of $0.99. The stock went to a low of $0.96 during the session.

    Stock Snapshot

    $0.99

    Prev. Close

    18.03 Million

    Market Cap

    $0.96

    Day Low

    $1.03

    Open

    16.85 Million

    Number of Shares

    $1.06

    Day High

    -

    P/E ratio

    -0.52

    EPS (TTM)

    1.71

    Cash Flow per Share

    1.45

    Free Float in %

    2.40

    Book Value

    258,698

    Volume

    Biocept, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$1.03$1.06$0.96$0.96258,700
    2022-06-22$1.05$1.1$0.98$0.99229,700
    2022-06-21$1.09$1.1$1.02$1.0593,600
    2022-06-17$1.17$1.19$1.02$1.04148,400
    2022-06-16$1.2$1.21$1.11$1.1561,600
    2022-06-15$1.22$1.25$1.19$1.2171,200
    2022-06-14$1.24$1.25$1.19$1.2262,100
    2022-06-13$1.35$1.36$1.17$1.25188,000
    2022-06-10$1.45$1.47$1.35$1.3680,000
    2022-06-09$1.45$1.51$1.43$1.4344,200

    Contact Details

    9955 Mesa Rim Road
    San Diego, CA 92121
    United States

    Webiste:BIOC

    858 320 8200

    Company Information

    Employees-

    Beta0.72

    Sales or Revenue61.25 Million

    5Y Sales Change80.20%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring in order to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreaticobiliary cancer, and ovarian cancer. Its Target-Selector molecular technology enables detection of mutations and genome alterations with enhanced sensitivity and specificity, as well as is applicable to nucleic acid from circulating tumor DNA; and Target-Selector CTC and molecular platforms provide biomarker detection and monitoring capabilities. In addition, it offers laboratory services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians. Further, it is developing PCR-based assays for detecting the COVID-19 virus. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, laboratories, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. It has a partnership with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.

    Frequently Asked Questions

    icon

    What is the current Biocept, Inc. (BIOC) stock price?

    Biocept, Inc. (NASDAQ: BIOC) stock price is $0.96 as of the last check on Thursday, June 23. During the trading session, BIOC stock reached the peak price of $1.06 while $0.96 was the lowest point it dropped to.

    icon

    BIOC's industry and sector of operation?

    The NASDAQ listed BIOC is part of Biotechnology industry that operates in the broader Health Care sector. Biocept, Inc. , an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample.

    icon

    Who are the executives of BIOC?

    Mr. Samuel D. Riccitelli
    Interim Pres & CEO and Independent Chairman
    Dr. Lyle J. Arnold Ph.D.
    Chief Scientist & Member of Scientific Advisory Board
    Mr. Darrell Taylor Esq.
    Sr. VP, Gen. Counsel & Chief Compliance Officer
    Dr. Michael C. Dugan M.D.
    Sr. VP, Chief Medical Officer & Medical Director

    icon

    What is the BIOC stock price today?

    BIOC stock traded closed the last session at $0.96, which is $-0.03 or -2.88% lower than its previous close of $0.99. BIOC's current trading price is -2.34% lower than its 52-week high of $4.53 where as its distance from 52-week low of 0.98% is -78.77%.

    icon

    How many employees does BIOC have?

    Number of BIOC employees currently stands at -. BIOC operates from 9955 Mesa Rim Road, San Diego, CA 92121, United States.

    icon

    Link for BIOC official website?

    Official Webiste of $BIOC is: https://biocept.com

    icon

    How do I contact BIOC?

    BIOC could be contacted at BIOC operates from 9955 Mesa Rim Road, San Diego, CA 92121, United States, or at phone #858 320 8200 and can also be accessed through its website.

    icon

    How many shares of BIOC are traded daily?

    BIOC stock volume for the day was 258,698 shares while in the previous session number of BIOC shares traded was 258,700 . The average number of BIOC shares traded daily for last 3 months was 96.05 Thousands.

    icon

    How much did BIOC change today?

    The percentage change in BIOC stock occurred in the recent session was -2.88% while the dollar amount for the price change in BIOC stock was $-0.03.

    icon

    What price range BIOC stock been trading in?

    In the recent session, the day high for BIOC stock was $1.06 while the low for BIOC stock touched on the day was $0.96.

    icon

    What is the market cap of BIOC currently?

    The market value of BIOC currently stands at 18.03 Million with its latest stock price at $0.96 and 16.85 Million of its shares outstanding.